Michael Ittmann mostly deals with Prostate cancer, Cancer research, Cancer, Prostate and Internal medicine. His Prostate cancer research is multidisciplinary, incorporating perspectives in Carcinogenesis, Tumor progression, Metastasis and Pathology. His studies in Cancer research integrate themes in fields like DNA methylation, microRNA, Fibroblast growth factor, Regulation of gene expression and PTEN.
Michael Ittmann has included themes like Transcription factor and Cell growth in his Cancer study. His Prostate research includes elements of Basal, Anatomical pathology, Genitourinary system and Adenocarcinoma. His biological study spans a wide range of topics, including Missense mutation, Endocrinology, Lineage and Gene isoform.
Michael Ittmann mainly focuses on Cancer research, Prostate cancer, Internal medicine, Prostate and Cancer. Michael Ittmann has researched Cancer research in several fields, including Carcinogenesis, Signal transduction, PTEN and Fibroblast growth factor. His Prostate cancer study integrates concerns from other disciplines, such as Metastasis and Pathology.
His Internal medicine study combines topics in areas such as Endocrinology, Protein kinase B, Oncology and In vivo. Michael Ittmann works mostly in the field of Prostate, limiting it down to concerns involving Growth factor and, occasionally, Cytokine. His research investigates the connection between Cancer and topics such as DNA methylation that intersect with problems in Regulation of gene expression.
His scientific interests lie mostly in Cancer research, Prostate cancer, Internal medicine, Oncology and Cancer. His Cancer research research is multidisciplinary, incorporating perspectives in Methylation, Carcinogenesis, Fusion gene, Transcription factor and PI3K/AKT/mTOR pathway. His Prostate cancer research integrates issues from Tumor progression, Protein kinase B, Prostate and Standard of care.
His biological study deals with issues like Tumor microenvironment, which deal with fields such as Epigenomics. When carried out as part of a general Internal medicine research project, his work on Clinical recurrence is frequently linked to work in African american, therefore connecting diverse disciplines of study. His work on Kidney cancer is typically connected to Field based as part of general Cancer study, connecting several disciplines of science.
Michael Ittmann focuses on Cancer research, Wnt signaling pathway, Cell biology, Progenitor and Stromal cell. His studies in Cancer research integrate themes in fields like Cancer, Gene knockdown, In vivo and Small interfering RNA. Endometrial cancer is the focus of his Cancer research.
His study looks at the intersection of In vivo and topics like Lung squamous cell carcinoma with Cell. He interconnects Metabolic flux analysis, Lipogenesis, Citric acid cycle and Androgen receptor in the investigation of issues within Cell biology. His research in Progenitor intersects with topics in Transforming growth factor, Tissue homeostasis and WNT5A.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Jing Li;Clifford Yen;Danny Liaw;Katrina Podsypanina.
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton.
The New England Journal of Medicine (2016)
Widespread deregulation of microRNA expression in human prostate cancer.
M Ozen;C J Creighton;M Ozdemir;M Ozdemir;M Ittmann;M Ittmann.
Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee
Scott B. Shappell;George V. Thomas;Richard L. Roberts;Ron Herbert.
Cancer Research (2004)
Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2.
Sagrario Ortega;Michael Ittmann;Stephen H. Tsang;Michelle Ehrlich.
Proceedings of the National Academy of Sciences of the United States of America (1998)
An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family
Pasquale Delli Bovi;Anna Maria Curatola;Francis G. Kern;Angela Greco.
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: